3 Stocks To Watch In The Coming Week: Tesla, Delta Air, Pfizer
Investing.com | Dec 26, 2021 01:51AM ET
With stocks rebounding strongly during the past week, and some trading at record highs, investors will be looking for signs in the final week of 2021 whether that rally could extend into next year.
The S&P 500 set a new closing record Thursday following encouraging reports about the lower-than-expected economic risks posed by the Omicron variant of COVID-19. After the gains of the past week, the S&P 500 extended its year-end gains to 26%.
Still, uncertainty over the new strain’s impact on the economy may cause more market swings, as many business sectors face labor shortages and ongoing supply chain disruptions. Amid this uncertain economic environment, here are three large-cap stocks that we’re monitoring in the upcoming week:
1. Tesla/h2
Tesla (NASDAQ:TSLA) shares have staged a powerful rebound during the past week, surging more than 14% and climbing back above $1,000 a share.
This powerful rally has given bulls some hope that the electric carmaker will continue its upward trend next year, especially when its CEO, Elon Musk, is almost done selling a large chunk of his holdings.
Musk wrote on Twitter last week he is “almost done” trimming his stake in Tesla. So far, the world's wealthiest man has sold $15.4 billion of his stock in the company. These sales are meant to cover an estimated tax bill of over $10 billion because of options he’s expected to exercise.
Wedbush analyst Dan Ives wrote in a note:
“This declaration by Musk removes an overhang on the stock with selling pressure and negative perception issues now removed and the focus back on fundamental drivers for the Street.”
Tesla shares closed on Thursday at $1,067 after last week’s rally which extended the EV leader’s gains this year to almost 50%.
2. Delta Air/h2
Airline stocks are ending the year under pressure once again amid the chaos brought by Omicron’s rapid global spread.
Delta Air Lines (NYSE:NYSE:DAL) and other carriers reported Thursday that they have canceled dozens of Christmas Eve flights as COVID hit crews; an additional nearly 1,000 flights were scrapped on Christmas Day. "Winter weather and Omicron forced Delta Air Lines to scrub 344 flights on Saturday, of approximately 3,000 scheduled flights, after exhausting all options and resources to prevent those cancellations," a spokesperson for the company said, adding that the impact was likely to persist on Sunday.
“The nationwide spike in Omicron cases this week has had a direct impact on our flight crews and the people who run our operation,” United Airlines (NASDAQ:UAL) said in a statement on Thursday. “As a result, we’ve unfortunately had to cancel some flights and are notifying impacted customers in advance of them coming to the airport.”
Shares of Delta Air, the most valuable US carrier, have slipped 25% from their 52-week high. They closed on Thursday at $39.30.
Along with the pandemic-related hit, there are additional pressures likely to continue hurting airlines next year. The biggest among them is higher fuel costs which threaten airline earnings in the current quarter and beyond.
3. Pfizer /h2
Among large cap healthcare stocks, Pfizer (NYSE:PFE) is finishing 2021 on a strong note.
US regulators last week approved the company’s COVID pill for emergency use. The drug, Paxlovid, is expected to provide a strong weapon against the virus once production gears up, giving people at high risk of severe complications from the disease a way to avoid hospitalization.
In a large clinical trial, the oral therapy was shown to reduce hospitalizations by 88% when given to high-risk unvaccinated patients within five days of the start of symptoms. The New York City-based company, which is also the leading supplier of the mRNA-based COVID-fighting vaccine, plans to ramp up production of the pill next year, providing another revenue stream for PFE.
In November, the US government said it had ordered 10 million courses of the Pfizer pill for a price of nearly $5.3 billion—about $530 per treatment. Pfizer shares closed on Thursday at $58.71, after gaining almost 60% during the year.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.